New open-access journal on cannabis and cannabinoid research launching fall 2015

Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, April 24, 2015 – Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers (, is the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. The Journal will publish under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation. The medical use of cannabis has become a global phenomenon. There are now 1.1 million users of legal medical cannabis in the U.S. Increasing numbers of jurisdictions in the U.S. and around the world are allowing access to herbal cannabis, and a broad new range of policy initiatives are emerging to regulate cannabis production and use to conduct high-quality research. Topics in Cannabis and Cannabinoid Research will include: Biochemical process of the endocannabinoid system Cannabinoid receptors and signaling Pharmaceuticals based on cannabis and cannabinoids Optimal dosing and drug delivery Short- and long-term effects on the brain and behavior Toxicological studies Analgesic effects, including neuropathic pain and chronic nerve injury Neurological disorders, including epilepsy, multiple sclerosis, and glaucoma Use of cannabis as antinauseants and antispasmodics Immune function and chronic inflammation, including HIV Cancer and cancer-related treatment Screening and assessment for marijuana misuse and addiction Social, behavioral, and public health impact Ethics, regulation, legalization, and public policy Cannabis and Cannabinoid Research will build a central forum and repository for peer-reviewed open access papers, as more high-quality research is needed to move the field forward.

Visit Link